Distribution characteristics of moxifloxacin in human lung

QIAN Yan-rong,WAN Huan-ying,XIANG Yi,SHI Guo-chao,TAO Jing
2009-01-01
Abstract:AIM To investigate the intrapulmonary pharmacokinetics of moxifloxacin in human.METHODS Twenty patients underwent bronchoscopy at different timed intervals(2,4,12,and 24 h)after drug administration and bronchoalveolar lavage(BAL)samples were taken.Drug concentrations in plasma,BAL fluid,and alveolar macrophages(AM)were determined by high-pressure liquid chromatography.The concentrations in epithelial lining fluid(ELF)were calculated by the urea diffusion method and the pharma-cokinetic parameters in plasma,ELF,and AM were compared.RESULTS The maximal concentrations in plasma,ELF,and AM were(2.1 ± s 0.8),(51 ± 45),(603 ± 425)mg·L-1.The ratio of drug AUC in plsasma,ELF,and AM were 1:20:235.CONCLUSION BAL associated with HPLC is an efficient and safe method to study the intrapulmonary pharmacokinetics of moxifloxacin in human.During the period of 24 h after drug administration,moxifloxacin achieved much more higher concentrations in ELF and AM than those in plasma.
What problem does this paper attempt to address?